DK1250152T3 - Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer - Google Patents
Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancerInfo
- Publication number
- DK1250152T3 DK1250152T3 DK00986939.7T DK00986939T DK1250152T3 DK 1250152 T3 DK1250152 T3 DK 1250152T3 DK 00986939 T DK00986939 T DK 00986939T DK 1250152 T3 DK1250152 T3 DK 1250152T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- composition containing
- hyaluronic acid
- synergistic composition
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17337599P | 1999-12-28 | 1999-12-28 | |
| PCT/CA2000/001562 WO2001047561A1 (en) | 1999-12-28 | 2000-12-28 | Hyaluronic acid in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1250152T3 true DK1250152T3 (da) | 2013-08-26 |
Family
ID=22631719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00986939.7T DK1250152T3 (da) | 1999-12-28 | 2000-12-28 | Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7125858B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1250152B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4215429B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU784356B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2395493C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1250152T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ520312A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001047561A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1140198B1 (en) | 1999-01-13 | 2007-10-31 | Alchemia Oncology Pty Limited | Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs |
| US20020091095A1 (en) * | 1999-12-13 | 2002-07-11 | Phillips Nigel C. | Modulation of Fas and FasL expression |
| DE60036019T2 (de) * | 1999-12-13 | 2008-05-29 | Bioniche Life Sciences Inc., Belleville | Synthetische oligonukleotide die therapeutisch nützlich sind |
| AUPQ879500A0 (en) * | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
| US9066919B2 (en) | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
| WO2002061085A2 (en) | 2000-10-31 | 2002-08-08 | Ryan James W | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
| US7087586B2 (en) * | 2001-04-24 | 2006-08-08 | Bioniche Life Sciences, Inc. | Oligonucleotide compositions and their use to induce differentiation of cells |
| ITPD20020271A1 (it) | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
| EP1625851A4 (en) | 2003-05-16 | 2007-12-26 | Bbk Bio Corp | PREPARATION FOR PREVENTING CONTACT OF PATHOGEN BROOMS WITH A LIVING ORGANISM |
| US20060240084A1 (en) * | 2005-04-20 | 2006-10-26 | Xylos Corporation | Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use |
| CA2616607C (en) * | 2005-07-27 | 2015-06-02 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
| EP1922077A4 (en) * | 2005-09-07 | 2013-03-06 | Alchemia Oncology Pty Ltd | THERAPEUTIC COMPOSITIONS WITH HYALURON AND THERAPEUTIC ANTIBODIES AND TREATMENT PROCEDURES |
| CN101848702B (zh) | 2006-12-01 | 2013-07-17 | 安特里奥公司 | 两亲实体纳米粒子 |
| DE102009035586A1 (de) | 2009-07-31 | 2011-02-03 | Fresenius Kabi Deutschland Gmbh | Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs |
| NO2480669T3 (cg-RX-API-DMAC7.html) * | 2009-09-25 | 2018-04-07 | ||
| WO2012049654A1 (en) | 2010-10-13 | 2012-04-19 | Bioniche Life Sciences, Inc. | Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| JP2016537685A (ja) * | 2013-09-12 | 2016-12-01 | ディーエスエム アイピー アセッツ ビー．ブイ． | 眼球デバイス |
| EP3541358A1 (en) | 2016-11-21 | 2019-09-25 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| WO2020056191A1 (en) | 2018-09-13 | 2020-03-19 | Eirion Therapeutics, Inc. | Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors |
| US12702790B2 (en) | 2019-06-13 | 2026-08-11 | Hollister Incorporated | Reusable urinary catheter kits |
| LT3952973T (lt) | 2019-06-13 | 2023-07-10 | Hollister Incorporated | Daugkartinio naudojimo šlapimo kateterio produktai |
| WO2020263859A1 (en) | 2019-06-25 | 2020-12-30 | Hollister Incorporated | Reusable urinary catheter products |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| JP7500038B2 (ja) * | 2019-08-27 | 2024-06-17 | 国立研究開発法人物質・材料研究機構 | 炎症性サイトカイン産生抑制材、ヒアルロン酸誘導体、及び、ヒアルロン酸誘導体の製造方法。 |
| CA3181682A1 (en) * | 2020-07-17 | 2022-01-20 | Anil Kapur | Subcutaneous telomerase inhibitor compositions and methods for using same |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3172815A (en) * | 1962-04-24 | 1965-03-09 | Warner Lambert Pharmaceutical | Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof |
| US4152423A (en) * | 1971-11-19 | 1979-05-01 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunological agents |
| FR2160326B1 (cg-RX-API-DMAC7.html) * | 1971-11-19 | 1975-02-07 | Anvar | |
| CA1020460A (en) * | 1973-02-23 | 1977-11-08 | Wellcome Foundation Limited (The) | Isolation of immunostimulating glycopeptide from bacteria |
| US3976544A (en) * | 1973-06-19 | 1976-08-24 | The Agence Nationale De Valorisation De Le Recherche | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction |
| FR2374042A1 (fr) * | 1976-06-04 | 1978-07-13 | Merieux Inst | Nouveau medicament immunostimulant et son procede de preparation |
| JPS54140710A (en) * | 1978-03-10 | 1979-11-01 | Mitsui Toatsu Chem Inc | Anti-tumor substance and its preparation |
| DE3011461C2 (de) * | 1980-03-25 | 1986-10-30 | Dr. Madaus & Co, 5000 Köln | Verwendung von Propionibakterien |
| US4520019A (en) * | 1982-04-29 | 1985-05-28 | Ribi Immunochem Research, Inc. | Stable composition and preparation thereof |
| US4579941A (en) * | 1982-08-13 | 1986-04-01 | Mitsuitoatsu Chemicals, Inc. | Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent |
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
| DE3408768A1 (de) | 1984-03-09 | 1985-09-12 | Bayer Ag, 5090 Leverkusen | Immunstimulierende mittel |
| US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
| DE3689071T2 (de) | 1985-10-31 | 1994-02-10 | Univ Australian | Immunheilbehandlung. |
| US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US4837202A (en) | 1987-09-14 | 1989-06-06 | Pitman-Moore, Inc. | Method for stimulating the immune system |
| DE3818054C2 (de) | 1988-05-27 | 1994-02-17 | Biotest Pharma Gmbh | Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| EP0952855B1 (en) * | 1991-07-03 | 2005-07-27 | Meditech Research Limited | Use of hyaluronan in gene therapy |
| CA2122519C (en) | 1994-04-29 | 2001-02-20 | Rudolf Edgar Dr. Falk | Cancer treatment and metastasis prevention |
| AU691797B2 (en) * | 1993-01-29 | 1998-05-28 | Vetrepharm, Inc. | Immunotherapeutic composition |
| AU6362594A (en) | 1993-03-10 | 1994-09-26 | Miles Inc. | Hyaluronic acid used as a cancer treatment |
| IN181358B (cg-RX-API-DMAC7.html) * | 1995-02-14 | 1998-05-30 | Bioniche Inc | |
| AU1991097A (en) | 1996-03-15 | 1997-10-01 | Immunotherapy, Inc. | Dialdehydes as immunostimulatory adjuvants and cross-linkers for producing immunogenic preparations and generating pressure and cross-linked treated cells for enhancing and augmenting the immune response against cancers, tumors and pathogenic diseases |
| CA2208924A1 (en) | 1997-07-09 | 1999-01-09 | Hyal Pharmaceutical Corporation | Sparing paclitaxel by the use of hyaluronan |
| KR100533576B1 (ko) * | 1997-08-05 | 2005-12-05 | 바이오니취 라이프 사이언시즈 인코포레이티드 | 세포증식 및 세포사멸 조절용 조성물 및 방법 |
| NZ506406A (en) | 1998-02-18 | 2002-11-26 | Bioniche Life Sciences Inc | Compositions comprising Mycobacterium phlei DNA and methods for its use in the treatment of bladder cancer |
| WO2000033875A1 (en) | 1998-12-04 | 2000-06-15 | Bioniche Life Sciences Inc. | Chemotherapeutic composition and method |
| EP1140198B1 (en) * | 1999-01-13 | 2007-10-31 | Alchemia Oncology Pty Limited | Use of hyaluronan for the manufacture of a medicament for the enhancement of the efficacy of cytotoxic drugs |
| CA2266188A1 (en) | 1999-03-19 | 2000-09-19 | Stephen Chizick | Natural preparation for treatment of male pattern hair loss |
-
2000
- 2000-12-28 US US10/168,327 patent/US7125858B2/en not_active Expired - Fee Related
- 2000-12-28 AU AU23364/01A patent/AU784356B2/en not_active Ceased
- 2000-12-28 EP EP00986939.7A patent/EP1250152B1/en not_active Expired - Lifetime
- 2000-12-28 DK DK00986939.7T patent/DK1250152T3/da active
- 2000-12-28 JP JP2001548149A patent/JP4215429B2/ja not_active Expired - Fee Related
- 2000-12-28 WO PCT/CA2000/001562 patent/WO2001047561A1/en not_active Ceased
- 2000-12-28 CA CA2395493A patent/CA2395493C/en not_active Expired - Fee Related
- 2000-12-28 NZ NZ520312A patent/NZ520312A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1250152A1 (en) | 2002-10-23 |
| AU784356B2 (en) | 2006-03-16 |
| JP2003518510A (ja) | 2003-06-10 |
| US7125858B2 (en) | 2006-10-24 |
| CA2395493C (en) | 2010-06-22 |
| AU2336401A (en) | 2001-07-09 |
| JP4215429B2 (ja) | 2009-01-28 |
| WO2001047561A1 (en) | 2001-07-05 |
| NZ520312A (en) | 2003-08-29 |
| US20030176381A1 (en) | 2003-09-18 |
| EP1250152B1 (en) | 2013-05-15 |
| CA2395493A1 (en) | 2001-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2412368T3 (da) | Sammensætning til behandling af ar | |
| DE60014873D1 (de) | Synergistische zusammensetzungen zur krebsbehandlung | |
| DK1196163T3 (da) | Farmaceutiske sammensætninger til behandling af insulinresistens | |
| GB0010669D0 (en) | Compositions for treatment of disorders of the oesophagus | |
| DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
| IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| NO20006630D0 (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
| EE200200172A (et) | Ühendid isheemia ravimiseks | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DK1384478T3 (da) | Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet | |
| DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| DK1450606T3 (da) | Synergistiske sammensætninger til behandling af såsæd | |
| DK1156806T3 (da) | Farmaceutisk sammensætning indeholdende protonpumpeinhibitor | |
| DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
| DK1150991T3 (da) | Præparater til behandling af inflammatoriske reaktioner | |
| HUP0402341A3 (en) | Compositions containing thiazol-2-ylamines for the treatment of cancer | |
| DK1150681T3 (da) | Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed | |
| PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
| IL133760A0 (en) | Composition for the treatment of dandruff | |
| PT1165031E (pt) | Composicao do resorcinol | |
| NO20022000D0 (no) | 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon | |
| DK1224181T3 (da) | Substituerede pyrroler som antiproliferative midler til behandling af cancer | |
| DE60015133D1 (de) | Synergistische zusammensetzung von bioziden |